Search Results - "POLATO, K"

Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group by Manara, E, Basso, G, Zampini, M, Buldini, B, Tregnago, C, Rondelli, R, Masetti, R, Bisio, V, Frison, M, Polato, K, Cazzaniga, G, Menna, G, Fagioli, F, Merli, P, Biondi, A, Pession, A, Locatelli, F, Pigazzi, M

“…Recurrent molecular markers have been routinely used in acute myeloid leukemia (AML) for risk assessment at diagnosis, whereas their post-induction monitoring…”
Get full text

Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia by Paganin, M, Zecca, M, Fabbri, G, Polato, K, Biondi, A, Rizzari, C, Locatelli, F, Basso, G

“…The aim of the study was to analyze the impact of minimal residual disease (MRD) after reinduction therapy on the outcome of children with relapsed ‘high-risk’…”
Get full text

Comparative sequence analysis of incomplete DJH and TCR gene rearrangements in children with relapses of T-ALL by GERMANO, G, DEL GIUDICE, L, LO NIGRO, L, POLATO, K, GIARIN, E, PAGANIN, M, BASSO, G

Get full text

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group by Benetton, Maddalena, Merli, Pietro, Walter, Christiane, Hansen, Maria, Da Ros, Ambra, Polato, Katia, Tregnago, Claudia, Abrahamsson, Jonas, Strocchio, Luisa, Sonneveld, Edwin, Fogelstrand, Linda, Von Neuhoff, Nils, Reinhardt, Dirk, Hasle, Henrik, Pigazzi, Martina, Locatelli, Franco

“…Hematopoietic stem cell transplantation (HSCT) is a curative post-remission treatment in patients with acute myeloid leukemia (AML), but relapse after…”
Get full text